Cinolazepam

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Not to be confused with cinazepam, clonazepam, or camazepam.
Cinolazepam
Cinolazepam.svg
Cinolazepam3d.png
Clinical data
Trade names Gerodorm
AHFS/Drugs.com cinolazepam
Routes of
administration
Oral
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability 90–100%
Metabolism Hepatic
Biological half-life 9 hours[1]
Excretion Renal
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
Chemical and physical data
Formula C18H13ClFN3O2
Molar mass 357.8
3D model (Jmol)
Chirality Racemic mixture
 NYesY (what is this?)  (verify)

Cinolazepam[2] (marketed under the brand name Gerodorm)[3] is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Due to its strong sedative properties, it is primarily used as a hypnotic.

Cinolazepam is not approved for sale in the United States or Canada.

See also[edit]

References[edit]

  1. ^ Saletu, B.; G. Kindshofer; P. Anderer; J. Grunberger (1987). "Short-term sleep laboratory studies with cinolazepam in situational insomnia induced by traffic noise.". International Journal of Clinical Pharmacology Research. 7 (5): 407–18. PMID 2889679. 
  2. ^ US Patent 4388313 Novel 3-hydroxy-1,4-benzodiazepine-2-ones and process for the preparation thereof
  3. ^ Lannacher Romania (1999). "Gerodorm". Produse Gerot inregistrate in Romania (in Romanian). Archived from the original on 11 October 2006. Retrieved 17 August 2006. 

External links[edit]